Breaking News
Sort by:
Top Post
SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer Detection Test
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE […]
Compugen Announces Appointment of Alberto Sessa as Chief Financial Officer
Compugen Ltd. ( Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced […]
NeoImmuneTech's NT-I7 Creates a More Immunogenic Tumor Microenvironment when Associated with Pembrolizumab
NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, presented data that suggests that NT-I7 plus […]
Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations
Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to […]
Verseon Gains European Patent Protection for Potential Sight and Life-Saving Treatments
Verseon is pleased to announce that the European Patent Office has granted intellectual property protection […]
Elephas Announces $41.5 Million in Series B Funding
Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $41.5 million in Series […]
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer […]
Lytix Biopharma Appoints Stephen Worsley as Chief Business Officer
Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment […]
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy […]
IVX Health Announces Opening of New Infusion Centers in Connecticut
IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more